=4
Present in all 4 major European markets
+100
4 principal consultants with over 100 years industry experience
>$12bn
>$12bn in deal value in last 12 months for acquisitions of AESARA-supported products
+50
Experience in rare genetic disorders, infectious diseases, neuroscience, oncology, cardio-metabolic etc
=4
Present in all 4 major European markets
+100
4 principal consultants with over
100 years industry experience
>$12bn
>$12bn in deal value in last 12 months for acquisitions of AESARA-supported products
+50
Experience in rare genetic disorders, infectious diseases, neuroscience, oncology, cardio-metabolic etc
What We Offer
We help you answer key business questions such as:
How can we get our product reimbursed in Europe?
What evidence do we need to show value in Europe?
How do we get through European HTA?
How can our drug get a good price in Europe?
What should we invest in Europe – and when?
What We Offer
We help you answer key business questions such as:
How can we get our product reimbursed in Europe?
What evidence do we need to show value in Europe?
How do we get through European HTA?
How can our drug get a good price in Europe?
What should we invest in Europe – and when?
Who We Are
We are a unique blend of industry veteran access strategists; value evidence scientists; and creative graphic designers.
What We Do
We stay ahead of HTA policy and reimbursement trends to help
innovator biotechs succeed in European markets.
European market value & access
EU HTAR readiness
Reimbursement due diligence
Payer & HCP research & advisory boards
Value & access function design, optimization & training
Get In touch
Don’t hesitate to reach out for more information.
Contact Us
- Location: London, Paris, Verona, Zug
- Email : [email protected]
© 2023 All Rights Reserved.